Brand Name of Adalimumab
The brand name of adalimumab is Humira®. 1
Reference Product and Biosimilars
- Humira® is the original reference product manufactured by AbbVie Inc., North Chicago, IL 2
- Adalimumab is a recombinant human IgG1 monoclonal antibody that specifically binds to TNF-alpha 1
Available Biosimilar Brand Names
Multiple adalimumab biosimilars have been approved by the European Medicines Agency (EMA) and are available with the following brand names 2:
- Amgevita® (ABP 501/SB5) 2
- Imraldi® (GP2017) 2
- Hyrimoz®, Hefiya®, Halimatoz® (FKB 327) 2
- Hulio® (FKB327) 2
- Idacio®, Kromeya® (MSB11022) 2
Clinical Context
- Adalimumab (Humira®) is FDA-approved for multiple indications including rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, and uveitis 2, 1
- The drug is administered by subcutaneous injection, typically 40 mg every other week for most indications 2
- In the United States, two adalimumab biosimilars have received FDA interchangeability designation, allowing pharmacy-level substitution where state law permits 3